Microcrystalline Cellulose

Applications as binder, thickening agent, filler, anti-cracking agent, fat replacer, disintegrate, emulsifying
agent, absorbing agent
Pharma
Food
Cosmetics
Personal Care

Global demand
Growing by CAGR of 7%
US$ 974.7 million in 2023 and US$ 1,794.1 million by 2033

Largest Manufacturers:
Juku Orchem Private, Jining Six Best Excipients, FMC, Shandong Guangda, Asahi Kasei, Ahua
Pharmaceutical, JRS, Anhui Sunhere Pharmaceutical, Ashland, Wei Ming Pharmaceutical, QuFuShi Medical,
Aoda Pharmaceutical, Tembec, Huzhou Zhanwang Pharmaceutical, DFE Pharma, Accent Microcell, Linghu,
Xinwang Chemical, Mingtai

Key Developments:

In July 2021
DFE Pharma, a company that supplies pharmaceutical excipient solutions, introduced Pharmacel sMCC 90,
a silicified microcrystalline cellulose (MCC) product. It was designed to serve as an effective solution for
complex oral solid medication formulations.

In September 2022
Roquette Frères S.A., a renowned global provider of plant-based ingredients and a top supplier of
pharmaceutical and nutraceutical excipients, has announced the full acquisition of Crest Cellulose, an
excipient manufacturer based in India.

In December 2022
JRS PHARMA (J. RETTENMAIER & SÖHNE GmbH + Co KG) revealed plans to build a new manufacturing
plant in Cedar Rapids, Iowa. The facility, a two-story pre-cast building, will start construction in fall 2022
and begin operations in early 2024, producing Microcrystalline Cellulose products.